Compound Detail
CHEMBL2108931
CRISANTASPASE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL2108931 |
| Name | CRISANTASPASE |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
6
Known Names
7
Indications
1
Mechanisms
Drug Information
| Molecule Type | Enzyme |
| First Approval | 2023 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Asparagine hydrolytic enzyme | HYDROLYTIC ENZYME | Asparagine | ✓ | ✓ |
Indications
Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Hematologic Neoplasms Leukemia, Lymphoid Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin
Data from ChEMBL 36 via Core Engine